Myeloma Other
Clinical and laboratory diagnosis of von Willebrand disease
血管性血友病的临床及实验室诊断
New insights into genotype and phenotype of von Willebrand disease
血管性血友病遗传型和表型的新见解
Management of von Willebrand disease
血管性血友病的管理
Lasting power of new clotting proteins
新型凝血蛋白的持续效力
Risky business of inhibitors: Human leukocyte antigen haplotypes, gene polymorphisms, and immune responses
抑制物相关风险：人白细胞抗原单倍型、基因多态性及免疫反应
Tooling up the inhibitor toolbox: Optimal therapy for inhibitors
针对抑制物的治疗方案：抑制物最佳治疗策略
